PHVS insider files Form 144 to sell 6,888 shares

PHVS filing a Form 144 reporting proposed sale of 6,888 shares of Common (listed as Founders Shares) by an affiliated holder.

Rhea-AI Filing Summary

PHVS filing a Form 144 reporting proposed sale of 6,888 shares of Common (listed as Founders Shares) by an affiliated holder. The excerpt also lists completed 10b5-1 sales by Hans H. Schikan totaling specific trades on 04/22/2026, 04/23/2026, 04/29/2026, 04/30/2026, and 06/25/2026.

Insights

Insider Transactions Specialist

Form 144 records proposed resale and shows prior 10b5-1 dispositions.

The filing lists 6,888 shares of Founders Shares as the securities to be sold and identifies multiple 10b5-1 sales by Hans H. Schikan on 04/22/2026 (7,000 shares) and other dates. These historic trades are trade dates and per-trade proceeds are shown in the excerpt.

Cash-flow treatment and buyer counterparties are not stated in the excerpt; subsequent filings or broker reports would show settlement details.

Key Figures

Shares to be sold: 6,888 shares 10b5-1 sale on 04/22/2026: 7,000 shares 10b5-1 sale on 04/29/2026: 3,830 shares +2 more

5 metrics

Shares to be sold 6,888 shares Securities To Be Sold (Founders Shares)

10b5-1 sale on 04/22/2026 7,000 shares 10b5-1 Sales for Hans H. Schikan

10b5-1 sale on 04/29/2026 3,830 shares 10b5-1 Sales for Hans H. Schikan

10b5-1 sale on 04/30/2026 29,070 shares 10b5-1 Sales for Hans H. Schikan

10b5-1 sale on 06/25/2026 2,400 shares 10b5-1 Sales for Hans H. Schikan

Key Terms

10b5-1, Form 144, Founders Shares

3 terms

10b5-1 regulatory

"10b5-1 Sales for Hans H. Schikan Emmy Noetherweg 2 Leiden"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Founders Shares market

"Securities To Be Sold Common | 12/29/2015 | Founders Shares"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

What does PHVS's Form 144 report?

The Form 144 reports a proposed resale of 6,888 shares of Common (Founders Shares). The filing lists those securities and an affiliated broker-dealer by name.

Who executed recent insider sales shown in the excerpt?

The excerpt shows multiple 10b5-1 sales by Hans H. Schikan on specific dates including 04/22/2026 and 06/25/2026, with per-trade share counts and gross proceeds listed.

How many shares were sold on 04/30/2026 per the filing?

The excerpt lists a 10b5-1 sale on 04/30/2026 of 29,070 shares, with the gross proceeds figure provided in the same line of the table.

Does the Form 144 indicate how proceeds will be used?

The provided excerpt does not state use of proceeds or specify who receives sale proceeds; it lists the securities, broker information, and recent 10b5-1 trades without proceeds allocation language.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 04:49 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014983
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pharvaris N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	310712036410
Name of Person for Whose Account the Securities are To Be Sold	Hans H. Schikan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6888	234260.88	65407822	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/29/2015	Founders Shares	Issuer			6888	12/29/2015	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for Hans H. Schikan Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2400	84249.93
10b5-1 Sales for Hans H. Schikan Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	29070	881378.75
10b5-1 Sales for Hans H. Schikan Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3830	115165.04
10b5-1 Sales for Hans H. Schikan Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for Hans H. Schikan Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7000	210378.70

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Hans H. Schikan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)